Odyssey Health, Inc. (ODYY)
OTCMKTS · Delayed Price · Currency is USD
0.0330
+0.0030 (10.00%)
Dec 31, 2025, 4:00 PM EST

Odyssey Health Cash Flow Statement

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Oct '25 Jul '25 Jul '24 Jul '23 Jul '22 Jul '21 2016 - 2020
Net Income
-1.21-1.74-0.84-5.92-8.44-16.88
Upgrade
Depreciation & Amortization
--0000.01
Upgrade
Other Amortization
0.070.050.330.530.690.86
Upgrade
Loss (Gain) From Sale of Assets
---16.4---
Upgrade
Asset Writedown & Restructuring Costs
-0.02----8.26
Upgrade
Loss (Gain) From Sale of Investments
0.090.4614.59---
Upgrade
Stock-Based Compensation
0.050.110.582.823.872.01
Upgrade
Other Operating Activities
0.110.020.010.170.071.24
Upgrade
Change in Accounts Payable
-0.010.23-0.20.250.321
Upgrade
Change in Other Net Operating Assets
0.540.530.710.670.310.08
Upgrade
Operating Cash Flow
-0.38-0.35-1.22-1.47-3.18-3.42
Upgrade
Sale of Property, Plant & Equipment
--1---
Upgrade
Sale (Purchase) of Intangibles
----0.01-0.05-
Upgrade
Investment in Securities
0.070.07----
Upgrade
Investing Cash Flow
0.070.071-0.01-0.05-
Upgrade
Short-Term Debt Issued
-0.30.40.90.381.57
Upgrade
Total Debt Issued
0.290.30.40.90.381.57
Upgrade
Short-Term Debt Repaid
---0.27-0.04-0.11-0.42
Upgrade
Total Debt Repaid
---0.27-0.04-0.11-0.42
Upgrade
Net Debt Issued (Repaid)
0.290.30.130.870.271.15
Upgrade
Issuance of Common Stock
--0.060.582.472.94
Upgrade
Other Financing Activities
-0.01-0.01----0.17
Upgrade
Financing Cash Flow
0.280.290.181.452.743.92
Upgrade
Net Cash Flow
-0.030.02-0.03-0.04-0.480.49
Upgrade
Free Cash Flow
-0.38-0.35-1.22-1.47-3.18-3.42
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.01-0.02-0.04-0.04
Upgrade
Cash Interest Paid
000.04000.03
Upgrade
Levered Free Cash Flow
0.150.13-0.630.62-0.430.32
Upgrade
Unlevered Free Cash Flow
0.250.24-0.640.47-0.60.13
Upgrade
Change in Working Capital
0.530.750.510.920.641.09
Upgrade
Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.